Cubist Asks High Court To Review Nixing Of Cubicin Patents

Lower courts erred by effectively creating new rules for evaluating a patent's obviousness when they examined and invalidated the asserted claims of four of the five patents covering the antibiotic Cubicin,...

Already a subscriber? Click here to view full article